Agenus reports FY2023 net loss of $257M, revenue $156M; BOT/BAL data in CRC shows 24% ORR

AGENUS INC

FY2023 revenue $156M, net loss $257M ($0.69 EPS); Q4 revenue $84M, net loss $49M ($0.13 EPS).
Ended 2023 with $76.1M cash; received $25M milestone from BMS in Jan 2024.
BOT/BAL in refractory MSS mCRC NLM: 24% ORR (vs 1-6% SOC), 12-month OS rate 74%.
Phase 2 topline data expected 2H2024; Fast Track designation granted.
Advancing monetization of non-strategic assets; potential $100-200M cash proceeds; partnership discussions ongoing.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

AGENUS INC reported year ended December 31, 2023 results: revenue $156 million, net income -$257 million, EPS -$0.69 per share.

Period: year ended December 31, 2023
Revenue: $156 million
Net income: -$257 million
EPS: -$0.69 per share
Result: reported results

Exact text from the filing

For the year ended December 31, 2023, we recognized revenue of $156 million and incurred a net loss of $257 million, or $0.69 per share.

View on SEC.gov

168 earnings releases filed in the last 30 days. Browse all earnings releases →

AGENUS INC filing history →

Source: SEC EDGAR

accession 0000950170-24-031148

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.